7900   Hyperthyroidism, including, but not limited to, Graves' disease: For six months after initial diagnosis 30
7903   Hypothyroidism: Hypothyroidism manifesting as myxedema (cold intolerance, muscular weakness, cardiovascular involvement (including, but not limited to hypotension, bradycardia, and pericardial effusion), and mental disturbance (including, but not limited to dementia, slowing of thought and depression)) 100
7903   Hypothyroidism: Note (1): This evaluation shall continue for six months beyond the date that an examining physician has determined crisis stabilization. Thereafter, the residual effects of hypothyroidism shall be rated under the appropriate diagnostic code(s) within the appropriate body system(s) (e.g., eye, digestive, and mental disorders). Hypothyroidism without myxedema 30
7904   Hyperparathyroidism: For six months from date of discharge following surgery 100
7904   Hyperparathyroidism: Note (1): After six months, rate on residuals under the appropriate diagnostic code(s) within the appropriate body system(s) based on a VA examination. Hypercalcemia (indicated by at least one of the following: Total Ca greater than 12 mg/dL (3-3.5 mmol/L), Ionized Ca greater than 5.6 mg/dL (2-2.5 mmol/L), creatinine clearance less than 60 mL/min, bone mineral density T-score less than 2.5 SD (below mean) at any site or previous fragility fracture) 60
7904   Hyperparathyroidism: Note (2): Where surgical intervention is indicated, this evaluation shall continue until the day of surgery, at which time the provisions pertaining to a 100-percent evaluation shall apply. Note (3): Where surgical intervention is not indicated, this evaluation shall continue for six months after pharmacologic treatment begins. After six months, rate on residuals under the appropriate diagnostic code(s) within the appropriate body system(s) based on a VA examination. Symptoms such as fatigue, anorexia, nausea, or constipation that occur despite surgery; or in individuals who are not candidates for surgery but require continuous medication for control 10
7904   Hyperparathyroidism: Asymptomatic 0
7905   Hypoparathyroidism: For three months after initial diagnosis 100
7906   Thyroiditis: With normal thyroid function (euthyroid) 0
7907   Cushing's syndrome: As active, progressive disease, including areas of osteoporosis, hypertension, and proximal upper and lower extremity muscle wasting that results in inability to rise from squatting position, climb stairs, rise from a deep chair without assistance, or raise arms 100
7907   Cushing's syndrome: Proximal upper or lower extremity muscle wasting that results in inability to rise from squatting position, climb stairs, rise from a deep chair without assistance, or raise arms 60
7907   Cushing's syndrome: With striae, obesity, moon face, glucose intolerance, and vascular fragility 30
7908   Acromegaly: Evidence of increased intracranial pressure (such as visual field defect), arthropathy, glucose intolerance, and either hypertension or cardiomegaly 100
7908   Acromegaly: Arthropathy, glucose intolerance, and hypertension 60
7908   Acromegaly: Enlargement of acral parts or overgrowth of long bones 30
7909   Diabetes insipidus: For three months after initial diagnosis 30
7909   Diabetes insipidus: Note: Thereafter, if diabetes insipidus has subsided, rate residuals under the appropriate diagnostic code(s) within the appropriate body system. With persistent polyuria or requiring continuous hormonal therapy 10
7911   Addison's disease (adrenocortical insufficiency): Four or more crises during the past year 60
7911   Addison's disease (adrenocortical insufficiency): Three crises during the past year, or; five or more episodes during the past year 40
7911   Addison's disease (adrenocortical insufficiency): One or two crises during the past year, or; two to four episodes during the past year, or; weakness and fatigability, or; corticosteroid therapy required for control 20
7913   Diabetes mellitus: Requiring more than one daily injection of insulin, restricted diet, and regulation of activities (avoidance of strenuous occupational and recreational activities) with episodes of ketoacidosis or hypoglycemic reactions requiring at least three hospitalizations per year or weekly visits to a diabetic care provider, plus either progressive loss of weight and strength or complications that would be compensable if separately evaluated 100
7913   Diabetes mellitus: Requiring one or more daily injection of insulin, restricted diet, and regulation of activities with episodes of ketoacidosis or hypoglycemic reactions requiring one or two hospitalizations per year or twice a month visits to a diabetic care provider, plus complications that would not be compensable if separately evaluated 60
7913   Diabetes mellitus: Requiring one or more daily injection of insulin, restricted diet, and regulation of activities 40
7913   Diabetes mellitus: Requiring one or more daily injection of insulin and restricted diet, or; oral hypoglycemic agent and restricted diet 20
7913   Diabetes mellitus: Manageable by restricted diet only 10
7914   Neoplasm, malignant, any specified part of the endocrine system 100
